Efficacy, Safety, PK, PD, and ADA of Eculizumab in Chinese Adults With NMOSD
Clinical trial NCT06724809 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06724809
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-16
- Primary completion
- 2026-12-07
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.